Affimed N.V. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (27)

Latest Posts

About This Stock More About This Stock
Morning Call For Wednesday, August 29
Article By: Jim Van Meerten
Wednesday, August 29, 2018 7:59 AM EDT
Sep E-mini S&Ps (ESU18 +0.04%) this morning are up +0.01% in quiet trade and rose on optimism that a U.S./Canada trade deal can be reached.
In this article: BOX, HRB, NCS, RCL, WTW, AVNW, PSEC, SCVL, AFMD, HPE, INST, TLRD, CDEV, ROKU, TLRY
Read
Calithera Pharma In Focus, Part 3 - Arginase Inhibitor And Acquisition Target
Article By: Scott Matusow
Monday, January 9, 2017 7:51 AM EDT
In the last part of our series on Calithera Biosciences we will be examining the company's second clinical asset and its acquisition chances sometime this year or early 2018.
In this article: CALA Also: GILD, BMY, AMGN, FPRX, AFMD
Read
Calithera Pharma In Focus, Part 1 - Checkpoint Inhibition
Article By: Scott Matusow
Wednesday, November 16, 2016 7:21 AM EDT
Clinical stage company Calithera presents an early stage investment opportunity with the ability to enhance therapeutic value to the first wave of IO therapeutics checkpoint inhibitors from Merck's Keytruda and Bristol-Myers Squibb's Opdivo.
In this article: CALA Also: AFMD, BMY, FPRX, BLUE, KITE, AZN, MRK, PFE, ADAP
Read

PARTNER HEADLINES

Latest Tweets for $AFMD

No tweets yet!